Drug Type CAR-T |
Synonyms- |
Target |
Action inhibitors |
Mechanism FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors), Gene transference |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
FLT3 positive Acute Myeloid Leukemia | Phase 2 | China | 31 Dec 2021 | |
Refractory acute myeloid leukemia | Phase 2 | China | 31 Dec 2021 | |
Relapsing acute myeloid leukemia | Phase 2 | China | 31 Dec 2021 |